Infection kits

Mycobacterium leprae nucleic acid detection kit

Leprosy is a chronic infectious disease caused by Mycobacterium leprae and Mycobacterium leprae. It is mainly transmitted through droplets but is not highly contagious. There are no symptoms in the early stages of infection, and the incubation period can be up to 5 to 20 years. The disease causes granulomas in the nervous system, respiratory tract, skin and eyes, resulting in loss of pain perception in the affected area, often causing repeated injuries to the limbs and requiring amputation. Symptoms of weakness and poor vision may also occur.

This kit is used for in vitro qualitative detection of Mycobacterium leprae FolP1, RpoB, and GyrA genes in skin tissue specimens of suspected Mycobacterium leprae cases or other persons who need to be diagnosed and identified.

The test results of this kit are for clinical reference only and should not be used as the sole criterion for clinical diagnosis. It is recommended to conduct a comprehensive analysis of the condition in combination with the patient's clinical manifestations and other laboratory tests.

Human HLA-B*13:01 Gene Detection Kit

HLA-B*13:01 has been confirmed to be a risk site for leprosy patients to develop dapsone syndrome. Studies have shown that people with one HLA-B*13:01 risk allele have a 37.5-fold risk of adverse reactions after using dapsone compared to those without this gene; for people with two alleles, the risk of adverse reactions increases 110.8-fold.

This kit is used for in vitro qualitative detection of HLA-B*13:01 allele in blood samples of patients with Mycobacterium leprae, and can reduce the risk of drug hypersensitivity syndrome in leprosy patients taking dapsone.

Monkeypox virus nucleic acid detection kit

Monkeypox (MP) is a rare, sporadic, smallpox-like zoonotic infectious disease caused by infection with Monkeypox Virus (MPV). The main clinical manifestations are fever, rash, and lymphadenopathy. It has mainly occurred in Central Africa and West Africa in the past, with a mortality rate of 1%-10%, and effective protection can be obtained through vaccination. Since smallpox was eradicated in 1980 and smallpox vaccination was subsequently stopped, monkeypox vaccine has become the most important orthopoxvirus in the field of public health. Since early May 2022, multiple cases of monkeypox have been found in more than 20 non-endemic countries, and human-to-human transmission has occurred.

This kit is used for in vitro qualitative detection of the F3L gene of monkeypox in suspected cases of monkeypox or other specimens (rash, scabs, blister fluid, pustular fluid or whole blood specimens) that require diagnosis and differentiation.

The test results of this kit are for clinical reference only and should not be used as the sole criterion for clinical diagnosis. It is recommended to conduct a comprehensive analysis of the condition in combination with the patient's clinical manifestations and other laboratory tests.

Novel coronavirus nucleic acid (2019-nCoV RNA) liquid quality control

The essential control product isNon-fixed value quality control products. It is prepared by diluting the novel coronavirus pseudovirus with a negative diluent after digital PCR quantification, and participates in the whole process from RNA extraction to nucleic acid amplification. It is used for method validation and indoor quality control of laboratories related to the detection of 2019 novel coronavirus nucleic acid (2019-nCoV RNA), effectively monitoring the instrument status, personnel operation, and kit effectiveness, etc., to ensure the accuracy and reliability of the test results, but it is not used for reagent evaluation and positive and negative result judgment.